Does the media prefer PLSE or DCTH?

In the previous week, Pulse Biosciences and Pulse Biosciences both had 1 articles in the media. Pulse Biosciences' average media sentiment score of 0.59 beat Delcath Systems' score of 0.00 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer EYE or DCTH?

In the previous week, National Vision and National Vision both had 1 articles in the media. National Vision's average media sentiment score of 1.77 beat Delcath Systems' score of 0.00 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is DCTH or ENOV more profitable?

Delcath Systems has a net margin of 0.62% compared to Enovis' net margin of -49.92%. Enovis' return on equity of 10.32% beat Delcath Systems' return on equity. Company Net Margins Return on Equity Return on Assets Delcath Systems 0.62% 0.51% 0.46% Enovis -49.92% 10.32% 4.57%

Does the media refer more to DCTH or ENOV?

In the previous week, Enovis had 4 more articles in the media than Delcath Systems. MarketBeat recorded 5 mentions for Enovis and 1 mentions for Delcath Systems. Enovis' average media sentiment score of 0.40 beat Delcath Systems' score of 0.00 indicating that Enovis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Enovis 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor DCTH or KMTS?

In the previous week, Kestra Medical Technologies had 20 more articles in the media than Delcath Systems. MarketBeat recorded 21 mentions for Kestra Medical Technologies and 1 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.00 beat Kestra Medical Technologies' score of -0.02 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Kestra Medical Technologies 2 Very Positive mention(s) 2 Positive mention(s) 12 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to DCTH or INSP?

In the previous week, Inspire Medical Systems had 4 more articles in the media than Delcath Systems. MarketBeat recorded 5 mentions for Inspire Medical Systems and 1 mentions for Delcath Systems. Inspire Medical Systems' average media sentiment score of 1.12 beat Delcath Systems' score of 0.00 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Inspire Medical Systems 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Delcath Systems (DCTH) Competitors

$12.81 -0.04 (-0.31%)

Closing price 07/17/2026 04:00 PM Eastern

Extended Trading

$12.81 +0.00 (+0.01%)

As of 07/17/2026 04:23 PM Eastern

Compare

DCTH vs. PLSE, EYE, ENOV, KMTS, and INSP

Should you buy Delcath Systems stock or one of its competitors? MarketBeat compares Delcath Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Delcath Systems include Pulse Biosciences (PLSE), National Vision (EYE), Enovis (ENOV), Kestra Medical Technologies (KMTS), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

How does Delcath Systems compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

Pulse Biosciences presently has a consensus price target of $30.67, indicating a potential upside of 6.93%. Delcath Systems has a consensus price target of $22.17, indicating a potential upside of 73.04%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts plainly believe Delcath Systems is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Delcath Systems has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulse Biosciences	$350K	5,671.27	-$72.78M	-$1.10	N/A
Delcath Systems	$90.44M	4.89	$2.70M	$0.01	1,281.00

Pulse Biosciences has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market.

77.0% of Pulse Biosciences shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 74.0% of Pulse Biosciences shares are held by insiders. Comparatively, 19.4% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Pulse Biosciences and Pulse Biosciences both had 1 articles in the media. Pulse Biosciences' average media sentiment score of 0.59 beat Delcath Systems' score of 0.00 indicating that Pulse Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulse Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Delcath Systems has a net margin of 0.62% compared to Pulse Biosciences' net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulse Biosciences	N/A	-86.67%	-73.61%
Delcath Systems	0.62%	0.51%	0.46%

Summary

Delcath Systems beats Pulse Biosciences on 10 of the 15 factors compared between the two stocks.

How does Delcath Systems compare to National Vision?

National Vision (NASDAQ:EYE) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

In the previous week, National Vision and National Vision both had 1 articles in the media. National Vision's average media sentiment score of 1.77 beat Delcath Systems' score of 0.00 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

61.1% of Delcath Systems shares are held by institutional investors. 2.4% of National Vision shares are held by insiders. Comparatively, 19.4% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

National Vision has a net margin of 2.31% compared to Delcath Systems' net margin of 0.62%. National Vision's return on equity of 6.41% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	2.31%	6.41%	2.81%
Delcath Systems	0.62%	0.51%	0.46%

National Vision has higher revenue and earnings than Delcath Systems. National Vision is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.84	$29.60M	$0.57	36.37
Delcath Systems	$90.44M	4.89	$2.70M	$0.01	1,281.00

National Vision currently has a consensus target price of $30.08, indicating a potential upside of 45.12%. Delcath Systems has a consensus target price of $22.17, indicating a potential upside of 73.04%. Given Delcath Systems' higher possible upside, analysts clearly believe Delcath Systems is more favorable than National Vision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

National Vision has a beta of 1.04, suggesting that its stock price is 4% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market.

Summary

National Vision beats Delcath Systems on 10 of the 15 factors compared between the two stocks.

How does Delcath Systems compare to Enovis?

Delcath Systems (NASDAQ:DCTH) and Enovis (NYSE:ENOV) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

In the previous week, Enovis had 4 more articles in the media than Delcath Systems. MarketBeat recorded 5 mentions for Enovis and 1 mentions for Delcath Systems. Enovis' average media sentiment score of 0.40 beat Delcath Systems' score of 0.00 indicating that Enovis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Enovis	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Delcath Systems currently has a consensus target price of $22.17, indicating a potential upside of 73.04%. Enovis has a consensus target price of $41.71, indicating a potential upside of 54.19%. Given Delcath Systems' higher possible upside, research analysts plainly believe Delcath Systems is more favorable than Enovis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Enovis	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.70

Delcath Systems has a net margin of 0.62% compared to Enovis' net margin of -49.92%. Enovis' return on equity of 10.32% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Enovis	-49.92%	10.32%	4.57%

Delcath Systems has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market. Comparatively, Enovis has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market.

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 98.4% of Enovis shares are held by institutional investors. 19.4% of Delcath Systems shares are held by insiders. Comparatively, 2.9% of Enovis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Delcath Systems has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$90.44M	4.89	$2.70M	$0.01	1,281.00
Enovis	$2.28B	0.68	-$1.18B	-$19.88	N/A

Summary

Enovis beats Delcath Systems on 10 of the 17 factors compared between the two stocks.

How does Delcath Systems compare to Kestra Medical Technologies?

Delcath Systems (NASDAQ:DCTH) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

In the previous week, Kestra Medical Technologies had 20 more articles in the media than Delcath Systems. MarketBeat recorded 21 mentions for Kestra Medical Technologies and 1 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.00 beat Kestra Medical Technologies' score of -0.02 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kestra Medical Technologies	2 Very Positive mention(s)	2 Positive mention(s)	12 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Delcath Systems currently has a consensus price target of $22.17, suggesting a potential upside of 73.04%. Kestra Medical Technologies has a consensus price target of $27.83, suggesting a potential upside of 13.98%. Given Delcath Systems' stronger consensus rating and higher possible upside, equities analysts clearly believe Delcath Systems is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Delcath Systems has higher earnings, but lower revenue than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$90.44M	4.89	$2.70M	$0.01	1,281.00
Kestra Medical Technologies	$95.13M	15.04	-$113.81M	-$2.42	N/A

61.1% of Delcath Systems shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Delcath Systems has a net margin of 0.62% compared to Kestra Medical Technologies' net margin of -138.35%. Delcath Systems' return on equity of 0.51% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

Delcath Systems has a beta of 0.49, indicating that its share price is 51% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.47, indicating that its share price is 53% less volatile than the broader market.

Summary

Delcath Systems beats Kestra Medical Technologies on 13 of the 16 factors compared between the two stocks.

How does Delcath Systems compare to Inspire Medical Systems?

Delcath Systems (NASDAQ:DCTH) and Inspire Medical Systems (NYSE:INSP) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Inspire Medical Systems had 4 more articles in the media than Delcath Systems. MarketBeat recorded 5 mentions for Inspire Medical Systems and 1 mentions for Delcath Systems. Inspire Medical Systems' average media sentiment score of 1.12 beat Delcath Systems' score of 0.00 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inspire Medical Systems	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Inspire Medical Systems has higher revenue and earnings than Delcath Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$90.44M	4.89	$2.70M	$0.01	1,281.00
Inspire Medical Systems	$911.98M	1.60	$145.42M	$4.49	11.25

Delcath Systems has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market.

Delcath Systems currently has a consensus target price of $22.17, suggesting a potential upside of 73.04%. Inspire Medical Systems has a consensus target price of $81.26, suggesting a potential upside of 60.83%. Given Delcath Systems' stronger consensus rating and higher possible upside, analysts plainly believe Delcath Systems is more favorable than Inspire Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Inspire Medical Systems	2 Sell rating(s)	14 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.19

Inspire Medical Systems has a net margin of 14.33% compared to Delcath Systems' net margin of 0.62%. Inspire Medical Systems' return on equity of 10.35% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Inspire Medical Systems	14.33%	10.35%	8.81%

Summary

Inspire Medical Systems beats Delcath Systems on 11 of the 17 factors compared between the two stocks.

Get Delcath Systems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DCTH vs. The Competition

Export

Metric	Delcath Systems	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$442.23M	$7.35B	$6.86B	$12.28B
Dividend Yield	N/A	1.31%	2.67%	9.34%
P/E Ratio	1,281.00	50.09	27.25	23.92
Price / Sales	4.89	95.09	517.85	89.25
Price / Cash	245.05	26.29	52.99	60.41
Price / Book	4.07	7.03	10.69	6.18
Net Income	$2.70M	$162.30M	$3.59B	$332.29M
7 Day Performance	-1.54%	-2.22%	-2.20%	-2.05%
1 Month Performance	9.58%	-1.24%	1.63%	-2.18%
1 Year Performance	13.87%	6.83%	25.64%	17.67%

Delcath Systems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DCTH Delcath Systems	2.1875 of 5 stars	$12.81 -0.3%	$22.17 +73.0%	+13.9%	$442.23M	$90.44M	1,281.00	60	News Coverage Gap Down
PLSE Pulse Biosciences	1.6895 of 5 stars	$25.77 -0.5%	$30.67 +19.0%	+89.9%	$1.78B	$350K	N/A	140	Gap Down
EYE National Vision	3.9562 of 5 stars	$19.88 +3.0%	$30.08 +51.4%	-17.4%	$1.60B	$1.99B	34.94	13,138	Positive News
ENOV Enovis	3.8838 of 5 stars	$25.09 -4.4%	$41.71 +66.3%	+2.9%	$1.45B	$2.25B	N/A	7,802	News Coverage
KMTS Kestra Medical Technologies	1.2351 of 5 stars	$24.15 -2.4%	$27.40 +13.4%	+53.6%	$1.43B	$59.81M	N/A	300	News Coverage Positive News Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DCTH) was last updated on 7/19/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Delcath Systems (DCTH) Competitors

DCTH vs. PLSE, EYE, ENOV, KMTS, and INSP

How does Delcath Systems compare to Pulse Biosciences?

Summary

How does Delcath Systems compare to National Vision?

Summary

How does Delcath Systems compare to Enovis?

Summary

How does Delcath Systems compare to Kestra Medical Technologies?

Summary

How does Delcath Systems compare to Inspire Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCTH vs. The Competition

Delcath Systems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Delcath Systems (DCTH) Competitors

DCTH vs. PLSE, EYE, ENOV, KMTS, and INSP

How does Delcath Systems compare to Pulse Biosciences?

Do analysts rate PLSE or DCTH?

Which has better earnings & valuation, PLSE or DCTH?

Which has more volatility & risk, PLSE or DCTH?

Do insiders and institutionals believe in PLSE or DCTH?

Does the media prefer PLSE or DCTH?

Is PLSE or DCTH more profitable?

Summary

How does Delcath Systems compare to National Vision?

Does the media prefer EYE or DCTH?

Do insiders & institutionals have more ownership in EYE or DCTH?

Is EYE or DCTH more profitable?

Which has higher valuation & earnings, EYE or DCTH?

Do analysts rate EYE or DCTH?

Which has more volatility and risk, EYE or DCTH?

Summary

How does Delcath Systems compare to Enovis?

Does the media refer more to DCTH or ENOV?

Do analysts rate DCTH or ENOV?

Is DCTH or ENOV more profitable?

Which has more risk & volatility, DCTH or ENOV?

Do insiders and institutionals believe in DCTH or ENOV?

Which has higher valuation & earnings, DCTH or ENOV?

Summary

How does Delcath Systems compare to Kestra Medical Technologies?

Does the media favor DCTH or KMTS?

Do analysts rate DCTH or KMTS?

Which has higher valuation & earnings, DCTH or KMTS?

Do institutionals & insiders hold more shares of DCTH or KMTS?

Is DCTH or KMTS more profitable?

Which has more volatility and risk, DCTH or KMTS?

Summary

How does Delcath Systems compare to Inspire Medical Systems?

Do insiders & institutionals hold more shares of DCTH or INSP?

Does the media refer more to DCTH or INSP?

Which has better valuation & earnings, DCTH or INSP?

Which has more volatility and risk, DCTH or INSP?

Do analysts rate DCTH or INSP?

Is DCTH or INSP more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCTH vs. The Competition

Delcath Systems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools